The Contribution of Nutrition in Compression Therapy for Chronic Venous Disease
DOI:
https://doi.org/10.14738/jbemi.73.8493Keywords:
compression therapy, chronic venous disease, venous ulcer, venotonicAbstract
Compression therapy is an essential step for the treatment of chronic venous disease (CVD). It is a mechanical treatment against the venous wall's persistent pathological change and the CVD created by inner metabolic substances that damage the wall and valves. The damage is possible to prevent using flavonoid drug and daily nutrition intake, which support the mechanical therapy positively.
References
(1) Kucukguven A, Khalil RA. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Curr Drug Targets. 2013 March 1; 14(3): 287–324.
(2) O’Donnel TF, Passman MA, Marston WA, Ennis WJ, Dalsing M, Kistner R et al. Management of venous leg ulcers: Clinical practice guidelines. 2014
(3) Partsch B, Partsch H. Calf compression pressure required to achievevenous closure from supine to standing positions. J Vasc Surg 2005;42:734-8
(4) Glinski, W.; Chodynicka, B.; Roszkiewicz, J.; Bogdanowski, T.; Lecewicz-Toru ´n, B.; Kaszuba, A.; Bowszyc, J.; Nowak, A.; Wnorowski, J.; W ˛asik, F.; et al. The Beneficial Augmentative Effect of Micronised Purified Flavonoid Fraction (MPFF) on the Healing of Leg Ulcers: An Open, Multicentre, Controlled, Randomised Study. Phlebology 1999, 14, 151–157.
(5) Roztocil, K.; Stvrtinova, V.; Strejcek, J. Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency. Int. Angiol. 2003, 22, 24–31.
(6) Guilhou, J.J.; Dereure, O.; Marzin, L.; Ouvry, P.; Zuccarelli, F.; Debure, C.; Van Landuyt, H.; Gillet-Terver, M.N.; Guillot, B.; Levesque, H.; et al. Efficacy of Daflon 500 mg in venous leg ulcer healing: A double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 1997, 48, 77–85.
(7) Wissing UE, Wengstrom Y, Skold G, Unosson M. Can individualized nutritional support improve healing in therapy-resistant leg ulcers? J Wound Care 2002;11:15-20.
(8) Rojas AI, Phillips TJ. Patients with chronic leg ulcers show diminished levels of vitamin A and E, carotenes, and zinc. Dermatol Surg 1999;25:601-4
(9) Jain SK, Rains J, Croad J, Larson B, Jones K. Curcumin Supplementation Lowers TNF-α, IL-6, IL-8, and MCP-1 Secretion in High Glucose-Treated Cultured Monocytes and Blood Levels of TNF-α, IL-6, MCP-1, Glucose, and Glycosylated Hemoglobin in Diabetic Rats. Antioxid Redox Signal. 2009 Feb; 11(2): 241–249.
(10) Supriono, Pratomo B, Kriestian M. Effects of Curcumin Against Matrix Metalloproteinase-2 (MMP-2) and Tissue Inhibitor Metalloproteinase-2 (TIMP-2) Serum Level on Rat Model of Liver Fibrosis Resolution Process. The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy. 2018; 19(1):10-15
(11) Kumar D, Kumar M, Saravanan C, Singh SK. Curcumin: A potential candidate for matrix metalloproteinase inhibitors. 2012.Expert Opinion on Therapeutic Targets 16(10):959-72
(12) Williams A. A review of the evidence for adjustable compression wrap devices. 2016. Available: https://lymphoedemaeducation.com.au/wp-content/uploads/2017/06/3b.-A-review-of-the-evidence-for-adjustable-compression-wrap-devices. (upload June 11, 2020)
(2) O’Donnel TF, Passman MA, Marston WA, Ennis WJ, Dalsing M, Kistner R et al. Management of venous leg ulcers: Clinical practice guidelines. 2014
(3) Partsch B, Partsch H. Calf compression pressure required to achievevenous closure from supine to standing positions. J Vasc Surg 2005;42:734-8
(4) Glinski, W.; Chodynicka, B.; Roszkiewicz, J.; Bogdanowski, T.; Lecewicz-Toru ´n, B.; Kaszuba, A.; Bowszyc, J.; Nowak, A.; Wnorowski, J.; W ˛asik, F.; et al. The Beneficial Augmentative Effect of Micronised Purified Flavonoid Fraction (MPFF) on the Healing of Leg Ulcers: An Open, Multicentre, Controlled, Randomised Study. Phlebology 1999, 14, 151–157.
(5) Roztocil, K.; Stvrtinova, V.; Strejcek, J. Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency. Int. Angiol. 2003, 22, 24–31.
(6) Guilhou, J.J.; Dereure, O.; Marzin, L.; Ouvry, P.; Zuccarelli, F.; Debure, C.; Van Landuyt, H.; Gillet-Terver, M.N.; Guillot, B.; Levesque, H.; et al. Efficacy of Daflon 500 mg in venous leg ulcer healing: A double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 1997, 48, 77–85.
(7) Wissing UE, Wengstrom Y, Skold G, Unosson M. Can individualized nutritional support improve healing in therapy-resistant leg ulcers? J Wound Care 2002;11:15-20.
(8) Rojas AI, Phillips TJ. Patients with chronic leg ulcers show diminished levels of vitamin A and E, carotenes, and zinc. Dermatol Surg 1999;25:601-4
(9) Jain SK, Rains J, Croad J, Larson B, Jones K. Curcumin Supplementation Lowers TNF-α, IL-6, IL-8, and MCP-1 Secretion in High Glucose-Treated Cultured Monocytes and Blood Levels of TNF-α, IL-6, MCP-1, Glucose, and Glycosylated Hemoglobin in Diabetic Rats. Antioxid Redox Signal. 2009 Feb; 11(2): 241–249.
(10) Supriono, Pratomo B, Kriestian M. Effects of Curcumin Against Matrix Metalloproteinase-2 (MMP-2) and Tissue Inhibitor Metalloproteinase-2 (TIMP-2) Serum Level on Rat Model of Liver Fibrosis Resolution Process. The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy. 2018; 19(1):10-15
(11) Kumar D, Kumar M, Saravanan C, Singh SK. Curcumin: A potential candidate for matrix metalloproteinase inhibitors. 2012.Expert Opinion on Therapeutic Targets 16(10):959-72
(12) Williams A. A review of the evidence for adjustable compression wrap devices. 2016. Available: https://lymphoedemaeducation.com.au/wp-content/uploads/2017/06/3b.-A-review-of-the-evidence-for-adjustable-compression-wrap-devices. (upload June 11, 2020)
Downloads
Published
2020-06-30
How to Cite
Yuwono, H. S. ., & Pratama, D. . (2020). The Contribution of Nutrition in Compression Therapy for Chronic Venous Disease. British Journal of Healthcare and Medical Research, 7(3), 09–12. https://doi.org/10.14738/jbemi.73.8493
Issue
Section
Original Articles
